Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑8 (Nos. 333-209949, 333-208543, 333-203235, 333-198499, and 333-193963) and the Registration Statements on Form S-3 (Nos. 333-210001 and 333-207469) of Revance Therapeutics Inc. of our report dated February 28, 2017 relating to the financial statements, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP
San Jose, California

February 28, 2017